Around 150 patients with germinal center diffuse large B cell lymphoma (DLBCL) or follicular lymphoma, stratified into those expressing mutant EZH2 and those expressing wild type EZH2, as
HuATN-658 is designed to target the cell surface protein uPAR, which is found in high levels in some of the most deadly cancers. As part of the deal,
The launch of this product follows receipt of the final approval from the US Food and Drug Administration (FDA) for an abbreviated new drug application (ANDA). IGI Laboratories
For Trulicity, Eli Lilly Japan has secured a manufacturing/marketing license as a drug indicated to treat people with type 2 diabetes in Japan. Trulicity is a once-weekly glucagon-like
The BLA for daratumumab is to treat MM patients who have received at least three prior lines of therapy including both a proteasome inhibitor (PI) and an immunomodulatory
Bexarotene 75mg capsules are a generic version of Valeant’s Targretin Capsules. Mylan CEO Heather Bresch said: "Mylan’s launch of the first and only generic Targretin is another example
Entocort (budesonide) is currently approved in more than 40 countries to treat Crohn’s disease (CD) and ulcerative colitis (UC). The US rights of Entocort will remain with AstraZeneca,
Entresto (previously known as LCZ696) will be provided on prescription for patients whose condition is classified NYHA class II-IV and indicated to reduce the risk of cardiovascular death
Earlier in March, the company received approval of an abbreviated new drug application (ANDA) for the product from the US Food and Drug Administration (FDA) The company’s product
As part of the deal, both the firms will jointly work to develop an adjuvanted non-alum based rPA vaccine. The deal provides PharmAthene exclusive worldwide rights to use
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.